AstraZeneca announced it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K.The purchase was valued at approximately 10 billion Japanese yen ($102 million) and gives AstraZeneca control of the entire shareholding of AstraZeneca K.K.
Marc Dunoyer, chief financial officer, AstraZeneca, said: “Our decision to gain full control of AstraZeneca K.K. reinforces our focus on Japan as a key growth platform.”
Date: March 26, 2014
Source: AstraZeneca
